A patient with Renal cell carcinoma is on treatment with Erythropoetin. Erythropoetin use may be associated with all of the following, except:
Treatment with erythropoietin stimulates erythrocyte production and results in an increase in reticulocyte count. Reticulocyte count is not decreased. So 'Decreased reticulocytes is the single best answer of choice'. Ref: Harrison's Principles of Internal Medicine, 16th Edition, Page 667
Decreased reticulocytes
Increased hemtocrit
Increased hemoglobin
Eliminates need for transfusion